GlassScriptPhysician profile
Homer T Keadle
NPI 1528227972
$6,856.65
in general payments reported to CMS, 2019-2025
37 companies · $3,361 in 2025
The $3,361 reported for 2025 was more than what 79% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $65.45 · 2021: $334 · 2022: $1,132 · 2023: $390 · 2024: $1,299 · 2025: $3,361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,821 · Travel and Lodging: $1,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,820.67 |
| Travel and Lodging | $1,229.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,499.25 | 2021-2025 | Indigo System, Penumbra System |
| Endologix LLC | $1,516.58 | 2022-2025 | Afx2 Bifurcated Endograft System, Endocross Device, Torus Stent Graft System |
| Medtronic, INC. | $476.74 | 2021-2025 | Endurant Iis, In.Pact Admiral, Hawkone |
| Smith+Nephew, INC. | $456.02 | 2020-2024 | Stravix, Grafix Xc, Grafix |
| Janssen Pharmaceuticals, INC | $242.86 | 2021-2024 | Xarelto |
| Bard Peripheral Vascular, INC. | $240.29 | 2019-2023 | Venovo |
| Boston Scientific Corporation | $201.02 | 2025 | General - Thrombectomy, Eluvia, Enroute Transcarotid Neuroprotection System |
| Philips North America LLC | $143.25 | 2024 | (Az7) Lasers |
| Shockwave Medical, INC | $119.88 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lemaitre Vascular, INC. | $91.96 | 2024-2025 | Artegraft Vascular Graft |
| Reflow Medical INC | $79.70 | 2025 | |
| Medtronic Vascular, INC. | $75.81 | 2019 | |
| Stryker Corporation | $74.07 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Polynovo North America LLC | $68.15 | 2024-2025 | Novosorb Btm |
| Humacyte Global, INC. | $63.20 | 2025 | Symvess |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $59.58 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Neuros Medical, INC. | $46.05 | 2025 | Altius |
| Ethicon US, LLC | $37.15 | 2020 | |
| Innovation Technologies INC | $28.31 | 2024 | Irrisept |
| Bolton Medical INC | $26.11 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Imperative Care, INC | $24.86 | 2024 | Prodigy Catheter |
| Novartis Pharmaceuticals Corporation | $24.81 | 2025 | |
| Solventum Corporation | $22.30 | 2024 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Convatec INC. | $20.43 | 2024 | |
| Artivion, INC. | $20.33 | 2021 | |
| Kci USA, INC. | $19.72 | 2023 | Prevena, V.A.C. Veraflo |
| Ossur Americas, INC. | $19.72 | 2024 | |
| Lifenet Health | $19.42 | 2024 | Theragenesis Wound Matrix |
| Cashflow Solutions, LLC | $18.00 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Kerecis Limited | $16.79 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $16.46 | 2020 | |
| Abbott Laboratories | $16.38 | 2024 | Esprit |
| Baxter Healthcare | $15.37 | 2022 | |
| Csl Behring | $15.07 | 2019 | |
| Angiodynamics, INC. | $14.75 | 2022 | |
| Becton, Dickinson and Company | $13.20 | 2024 | Venclose Maven Catheter |
| E.R. Squibb & Sons, L.L.C. | $13.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Homer Keadle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.